SRPT short interest
Sarepta Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 22,784,187 |
|---|---|
| Change vs prior report | -2,650,494 (-10.4%) |
| Change over six months | -11.4% |
| Days to cover | 8.62 (sector: 3.78) |
| Average daily volume | 2,644,045 |
| Rank in Healthcare | #174 of 922 by days to cover |
SRPT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 22,784,187 | -10.4% | 8.62 | 2,644,045 |
| 2026-09-15 | 25,434,681 | +3.3% | 8.02 | 3,170,287 |
| 2026-08-31 | 24,621,090 | -9.0% | 8.46 | 2,909,424 |
| 2026-08-14 | 27,049,885 | -1.9% | 9.07 | 2,983,896 |
| 2026-07-31 | 27,566,969 | -3.2% | 8.77 | 3,142,381 |
| 2026-07-15 | 28,489,470 | -0.8% | 9.22 | 3,089,173 |
| 2026-06-30 | 28,734,169 | +14.2% | 5.75 | 4,997,302 |
| 2026-06-15 | 25,167,342 | +0.1% | 9.10 | 2,767,049 |
| 2026-05-29 | 25,129,233 | +0.4% | 9.44 | 2,661,920 |
| 2026-05-15 | 25,018,640 | +0.4% | 7.32 | 3,417,876 |
| 2026-04-30 | 24,919,242 | -1.6% | 9.54 | 2,613,382 |
| 2026-04-15 | 25,334,475 | -1.5% | 11.47 | 2,208,962 |
| 2026-03-31 | 25,729,261 | +12.4% | 6.26 | 4,108,420 |
| 2026-03-13 | 22,887,634 | +7.7% | 9.10 | 2,515,096 |
| 2026-02-27 | 21,243,755 | -4.3% | 9.82 | 2,163,734 |
| 2026-02-13 | 22,199,070 | -0.1% | 9.39 | 2,363,933 |
| 2026-01-30 | 22,221,883 | +4.4% | 7.40 | 3,001,290 |
| 2026-01-15 | 21,277,328 | +4.0% | 6.50 | 3,274,433 |
| 2025-12-31 | 20,456,453 | +1.5% | 7.72 | 2,650,409 |
| 2025-12-15 | 20,155,205 | +3.0% | 6.34 | 3,180,144 |
| 2025-11-28 | 19,565,034 | +8.7% | 5.33 | 3,673,999 |
| 2025-11-14 | 17,999,403 | +4.0% | 2.15 | 8,374,179 |
| 2025-10-31 | 17,313,065 | -2.1% | 4.33 | 3,999,849 |
| 2025-10-15 | 17,686,193 | -9.8% | 2.75 | 6,424,974 |
| 2025-09-30 | 19,618,972 | -3.2% | 3.25 | 6,042,788 |
import finzdata as yf
yf.Ticker("SRPT").short_interest # every report since 2017
yf.Client().short_interest(["SRPT"], start="2018-01-01")Healthcare short interest · SRPT price history · Who owns SRPT · All short interest